Enzo Biochem Inc
(ENZB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 01-2019 | 10-2018 | 07-2018 | 04-2018 | 01-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,389 | -5,981 | -10,321 | -4,557 | -1,541 |
| Depreciation Amortization | 1,534 | 766 | 3,130 | 2,350 | 1,535 |
| Accounts receivable | 1,471 | 312 | 1,915 | 756 | 206 |
| Accounts payable and accrued liabilities | -1,746 | -2,361 | -887 | -2,126 | -809 |
| Other Working Capital | -2,998 | -1,526 | 2,339 | 1,264 | 665 |
| Other Operating Activity | 1,353 | 2,586 | 1,089 | 1,838 | 779 |
| Operating Cash Flow | $-14,775 | $-6,204 | $-2,735 | $-475 | $835 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,988 | -406 | -1,888 | -1,626 | -1,066 |
| Other Investing Activity | 0 | -609 | -56 | -51 | -10 |
| Investing Cash Flow | $-6,988 | $-1,015 | $-1,944 | $-1,677 | $-1,076 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 4,500 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | -59 | -327 | -299 | -190 |
| Common Stock Issued | 166 | 25 | 886 | 831 | 710 |
| Other Financing Activity | -210 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $4,456 | $-34 | $559 | $532 | $520 |
| Exchange Rate Effect | -6 | -11 | -6 | 9 | 22 |
| Beginning Cash Position | 60,041 | 60,041 | 64,167 | 64,167 | 64,167 |
| End Cash Position | 42,728 | 52,777 | 60,041 | 62,556 | 64,468 |
| Net Cash Flow | $-17,313 | $-7,264 | $-4,126 | $-1,611 | $301 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,775 | -6,204 | -2,735 | -475 | 835 |
| Capital Expenditure | -6,988 | -406 | -1,888 | -1,626 | -1,066 |
| Free Cash Flow | -21,763 | -6,610 | -4,623 | -2,101 | -231 |